期刊文献+

琥珀酸亚铁治疗孕期缺铁性贫血的疗效 被引量:4

Effect of ferrous succinate in the treatment of iron deficiency anemia during pregnancy
下载PDF
导出
摘要 目的深入分析琥珀酸亚铁治疗孕期缺铁性贫血的效果。方法根据临床资料,筛选出92例缺铁性贫血孕中晚期患者。采取随机分组的方式,将患者分为研究组和对照组,每组各46例。其中研究组对照组饮食条件和日常活动基本相同,而研究组患者在服用正常药物后需要另外服用琥珀酸亚铁。研究人员对两组患者的体征、疗效以及血液指标等进行监测。结果利用统计学理论对研究数据进行处理,发现研究组和对照组患者血液指标在治疗前差异无统计学意义(P> 0.05);而两组患者在治疗后血液各项指标差异有统计学意义(P <0.05);两组患者治疗前后的血清铁蛋白间的差异有统计学意义(P <0.05)。并且通过对两组患者临床治疗效果进行分析,发现研究组疗效(95.65%)远优于对照组(65.22%),差异有统计学意义(P <0.05)。结论目前治疗孕中晚期贫血最佳的药物为琥珀酸亚铁,具有较大的临床应用价值。 Objective To analyze the effect of ferrous succinate in the treatment of iron deficiency anemia during pregnancy. Methods According to the clinical data, 92 cases of this type were selected, that is, the middle and late pregnant women with iron deficiency anemia. The patients were divided into a study group and a control group, with 46 cases in each group. In the study group, the diet and daily activities of the control group were basically the same, while the patients in the study group needed another ferrous succinate after taking normal drugs. The researchers monitored the signs, efficacy and blood indicators of the two groups of patients. Results Using statistics theory, we found that there was no significant difference in blood index between the study group and the control group before treatment (P 〉 0.05), but there was a significant difference in blood indexes between the two groups after treatment (P 〈 0.05 ), there was a significant difference in serum ferritin between the two groups before and after treatment (P 〈 0.05). By analyzing the clinical effect of two groups of patients, we found that the curative effect ( 95.65% ) in the study group was much better than that in the control group ( 65.22% ), and there was a significant difference (P 〈 0.05). Conclusion The best drug for the treatment of middle and late gestational anemia is ferrous succinate, which is of great clinical value.
作者 蒋琳珊 JIANG Linshan(Obstetrics Department,the Traditional Chinese Medicine Hospital of Changzhou City,Jiangsu,Changzhou 213003,China)
出处 《中国医药科学》 2018年第16期46-48,共3页 China Medicine And Pharmacy
关键词 琥珀酸亚铁 孕中晚期 缺铁性贫血 血红蛋白 Ferrous sueeinate Middle and late pregnancy Iron deficiency anemia Hemoglobin
  • 相关文献

参考文献15

二级参考文献108

  • 1徐绍君,陈双郧.复方阿胶浆联合速力菲治疗妊娠期贫血210例效果观察[J].医学信息(医学与计算机应用),2014,0(2):141-141. 被引量:2
  • 2Seong-Joon Koh,Jong Pil Im,Ji Won Kim,Byeong Gwan Kim,Kook Lae Lee,Sang Gyun Kim,Joo Sung Kim,Hyun Chae Jung.Long-term outcome in patients with obscure gastrointestinal bleeding after negative capsule endoscopy[J].World Journal of Gastroenterology,2013,19(10):1632-1638. 被引量:12
  • 3中国儿童,孕妇,育龄妇女铁缺乏症流行病学调查协作组.中国孕妇、育龄妇女铁缺乏症患病率调查[J].中华血液学杂志,2004,25(11):653-657. 被引量:151
  • 4马明信.成人缺铁性贫血的治疗[J].中国全科医学,2006,9(19):1585-1586. 被引量:11
  • 5韩鹏飞,陈志会,鞠传余,等.血常规检测在鉴别缺铁性贫血和地中海贫血的临床应用[J].中国药物经济学,2014,18 (2): 262-263.
  • 6Alireza N, Saeedeh S, Azita Z, et al.The prevalenceof mediterranean mutation of glucose-6-phosphatedehydrogenase ( G6PD ) in Zahedan[J].Zahedan Journal ofResearch in Medical Sciences,2012,14 ( 3 ) : 735-746.
  • 7Narender T, Seema T, Jasmita D,et al.Aplastic anaemiawith microfilaria in marrow aspirate[J].MediterraneanJournal of Hematology and Infectious Diseases,2012,4(1 ): 203-208.
  • 8Alireza N, Saeedeh S, Azita Z,et al.The prevalenceof mediterranean mutation of dlucose-6-phosphatedehydrogenase ( G6PD ) in Zahedan[J].Zahedan Journal ofResearch in Medical Sciences,2012,14 ( 3 ): 738-740.
  • 9Hu X, Teng X, Zheng H, et al. Iron deficiency without anemia causes maternal hypothyroxinemia in pregnant rats [J]. Nutr Res, 2014,34(7) : 604,.
  • 10Ozcicek F, Aktas M, Tiarkmen K, et al. The investiga- tion of plasma glucose-6-phosphate dehydrogenase, 6-pho- shogluconate dehydrogenase, glutathione reductase in pre- menauposal patients with iron deficiency anemia[J]. Pak J MedSci, 2014,30(4) : 809.

共引文献137

同被引文献46

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部